Unraveling Candidiasis: Pathogenic Mechanisms and the Spectrum of Infections
DOI:
https://doi.org/10.22270/ajprd.v13i1.1520Abstract
Worldwide, fungal infections—especially those brought on by Candida species like Candida albicanscause a considerable amount of illness and mortality, particularly in people with weakened immune systems. Through morphological changes, adhesion, invasion, biofilm formation, and the release of hydrolytic enzymes, Candida albicans demonstrates complicated pathogenicity. Its pathogenicity is increased by its capacity to change phenotypes and adjust to shifting environmental conditions. Drug-resistant strains such as Candida auris are becoming more and more common, which emphasizes the urgent need for efficient therapies and a better comprehension of the mechanisms behind fungal pathogenicity. Oral and vulvovaginal infections are among the many forms of candidiasis caused by Candida species, especially Candida albicans. Whereas vulvovaginal candidiasis affects the female reproductive system, oral candidiasis presents as thrush. Hormonal fluctuations, antibiotic usage, and immunosuppression are risk factors. Antifungal drugs are one kind of treatment; recurrence is frequent in some groups. Candida species, including Candida albicans, are responsible for a number of illnesses, including invasive candidiasis, gastrointestinal infections, and skin infections. Immunocompromised people are more susceptible to these infections, which can range from localized skin and gastrointestinal colonization to potentially fatal systemic infections. Antifungal drugs such as amphotericin B, azoles, and echinocandins are used in treatment.
Downloads
References
Ignacio UM, Uriel MP, Salvador PH, Alejandra TT, Juan PL, Jose EG, Elizabeth RB. Candida albicans the main opportunistic pathogenic fungus in humans, Revista Argentina de Microbiología 55. 2023; 189,198.
Choi J, Kim SH. A genome tree of life for the fungi kingdom. ProcNatl AcadSci U S A. 2017; 114 (35):9391–9396. 1.
Peter G. Pappas, MD. Invasive Candidiasis, Infect Dis Clin N Am 20. 2006; 485–506.
Jose PL, Michail S.L. Pathogenesis and virulence of Candida albicans. Virulence. 2020; 13:1, 89-121.
Feng Z, Lu H, Jiang Y. Promising immunotherapeutic targets for treating candidiasis. Front. Cell. Infect. Microbiol.2024; 14:1339501.
Lu, H, Hong, T, Jiang, Y, Whiteway M., Zhang S. (2023a). Candidiasis: From cutaneous to systemic, new perspectives of potential targets and therapeutic strategies. Adv. Drug Delivery Rev. 1999; 114960.
Metin. Recurrent candidalintertrigo: challenges and solutions. Clinical, Cosmetic and Investigational Dermatology, 2018; 11 175–185.
De Oliveira Santos GC, Vasconcelos CC, Lopes AJO, de Sousa CartagenesMdS, Filho AKDB, do Nascimento FRF, Ramos RM, Pires ERRB, de Andrade MS, Rocha FMG and de Andrade Monteiro C. Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents. Front. Microbiol. 2018; 9:1351.
Talapko, J, Juzbasic M, Matijevic T, Pustijanac, E, Bekic, S, Kotris, I,Skrlec, I. Candida albicans—The Virulence Factors and Clinical Manifestations of Infection. J. Fungi 2021; 7, 79.
Delma S, Thompson, Patricia L, Carlisle, David K, Coevolution of Morphology and Virulence in Candida Species, Eukaryotic cell. 2011; p. 1173–1182, Vol. 10, No. 9.
Peter S, Neil G, and Judith B. The distinct morphogenic states of Candida albicans, Trend in Microbiology. 2004; Vol.12 No.7.
Lajean C, Jose L, Manuel C, Daniel G, Jose P. Cell wall and secreted proteins of candida albicans: Identification, Function, and Expression, Microbiology and molecular biology reviews. 1998; p. 130–180, Vol. 62, No. 1.
Francois L.M, Duncan W. Bernhard Hube, Candida albicans pathogenicity mechanisms. Virulence, 2013; 4:2, 119–128.
Ahmet M, Nursel D, Serap GB. Candida albicans: genetics, dimorphism and pathogenicity. International Microbiology. 1998, 1:95–106.
Sara HA, Khaled E, Gamal EH. Hussein HA. Candida diagnostic techniques: a review, J.Umm Al-Qura Univ. Appll. Sci. 2023; 9:360–377,
AlessandraSD, Kathy KL, Ingrida R, Katja S, Jeanette W, Bhawna Y and Neil AR Cell biology of Candida albicans–host interactions. Current Opinion in Microbiology. 2016; 34:111–118.
Richard AC, William AF. Virulence factors of Candida albicans. Trends in Microbiology, 2001; Vol.9. no 7.
Cristina NC, Irina BK, Anca DM, Felicia T, Ionela AP, Adrian M. Candida and Candidiasis—Opportunism Versus Pathogenicity: A Review of the Virulence Traits, Microorganisms. 2020; 8, 857.
Naglik, JR, Challacombe S.J, Hube, B. Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis. Microbiol. Mol. Biol. Rev. 2003; 67, 400–428.
Taissa V, Ahmed SS, Daniel MJ, Mary AJ. Oral Candidiasis: A Disease of Opportunity, J. Fungi.2020; 6, 15.
John WH, Cindy LM. Candidiasis: Red and White Manifestations in the Oral Cavity, Head and Neck Pathology. 2019; 13:25–32.
A Akpan, R Morgan. Oral candidiasis, Postgrad Med J. 2002;78:455–459.
Shin-Yu L. Oral Candidosis: Pathophysiology and Best Practice for Diagnosis, Classification, and Successful Management. J. Fungi. 2021; 7, 555.
Arun S, Renuka V, Aditi M, Ashutosh A. Oral candidiasis: An overview, Journal of Oral and Maxillofacial Pathology. 2014; Vol. 18 Supplement 1.
Garcia-Cuesta C, Sarrion-Perez MG, Bagan JV. Current treatment of oral candidiasis: A literature review. J ClinExp Dent. 2014;6(5): e576-82.
Joel BE, MSD, DMD,’ and Bruce P, DMD. Oropharyngeal Candidiasis: A Review of Its Clinical Spectrum and Current Therapies. Clinical therapeutics. 1998; VOL. 20, NO. 1.
Serrano J, Lopez-Pintor RM, Ramirez L, Fernandez-Castro M, Sanz M, Melchor S. Risk factors related to oral candidiasis in patients with primary Sjögren’s syndrome. Med Oral Patol Oral Cir Bucal. 2020 ;25 (5): e700-5.
Ketut S, Hamong S, Gede PJ. Factors Associated with Oral Candidiasis in People Living with HIV/AIDS: A Case Control Study, HIV/AIDS - Research and Palliative Care. 2020:12 33–39.
Patil S, Rao RS, Majumdar B, Anil S. Clinical Appearance of Oral Candida Infection and Therapeutic Strategies. Front. Microbiol.2015; 6:1391.
Coronado-Castellote L, Jiménez-Soriano Y. Clinical and microbiological diagnosis of oral candidiasis. J ClinExp Dent. 2013;5(5): e279-86.
Baumgardner DJ. Oral fungal microbiota: to thrush and beyond. J Patient Cent Res Rev. 2019; 6:252-61.
Bhakti S, Tabassum K. Recent advances in delivery of antifungal agents for therapeutic management of candidiasis Biomedicine & Pharmacotherapy, j.biopha .2017; 11.127.
Hubertine ME, Salman SA, Junyan L, Zhenbo X, Brian MP. Vulvovaginal Candidiasis: A Current Understanding and Burning Questions,J. Fungi 2020; 6, 27.
Yufei W, Zhaoxia L, Tingtao C. Vaginal microbiota: Potential targets for vulvovaginal candidiasis infection, Heliyon 10. 2024; e27239.
Juliana EM, Candidiasis (vulvovaginal),Clinical Evidence 2015;03:815
Paul N, Carolyn B, Gweneth L, Jane S, Jack DS. Vulvovaginal Candidiasis: A Review of the Evidence for the manage Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines. Clinical Infectious Diseases. 2022;74(S2): S162–8.
Andraz D, Andrej G, Dusan N, Darja A, Iztok T. Treatment of vulvovaginal candidiasis: a review of the literature. ActaDermatovenerologicaAlpina, Pannonica et Adriatica. 2015; 24:5-7.
Masahiro A, Yuki K, Takuro K, and Yoshitsugu M. Basic Research on Candida Species: Disease Mechanism, Virulence, and Relationship with Environmental Factors. Medical Mycology Journal. 2024; Volume 65.
Jose AV, MD, Jack DS, MD. Mucosal candidiasis. Infect Dis Clin N Am 16. 2002: 793–820.
Nahed G, Ali ER, Ghassan G, Jose-Noel I. Emergence of Vulvovaginal Candidiasis among Lebanese Pregnant Women: Prevalence, Risk Factors, and Species Distribution. Infectious Diseases in Obstetrics and Gynecology. 2019; Article ID 5016810.
Hashemi SE, Shokohi T, Abastabar M, Aslani N, Ghadamzadeh M, Haghani I. Species distribution and susceptibility profiles of Candida species isolated from vulvovaginal candidiasis, emergence of C. lusitaniae. Curr Med Mycol. 2019; 5(4): 26-34.
Melphine MH, Mairi CN. Importance of Candida–bacterial polymicrobial biofilms in disease,Trends in Microbiology. 2011; Vol. 19, No. 11.
Malgorzata J, Magdalena F, Irena Choroszy-Krol. The influence of diet on gastrointestinal Candida spp. Colonization. RoczPanstwZaklHig. 2019;70(2):195-200.
Anne NB, Christophe D, Marie-Elisabeth B. Candida albicans commensalism in the gastrointestinal tract. FEMS Yeast Research. 2015; Vol. 15, No. 7.
Alonso MR, Gresnigt MS, Roman E, Hube B, Pla J. Candida albicans colonization of the gastrointestinal tract: A double-edged sword. PLoSPathog. 2021 17(7): e1009710.
Kumamoto CA. Inflammation and gastrointestinal Candida colonization. Current Opinion in Microbiology. 2011; 14:386–391.
Taudorf EH, Jemec GB, Hay RJ,Saunte DM. Cutaneous candidiasis caused by Candida albicans in a young non-immunosuppressed patient: an unusual presentation. International Journal of Immunopathology and Pharmacology. 2018; Volume 32: 1–4.
Enzo P, Maurizio N, Grazia Z, Valeria D, Mattia C, Eleonora C, Donatella MR, Alessia B, Carla P, Cecilia A, Daniela S, Valeria P, Daniela F, Vincenzo P. Cutaneous candidiasis – an evidence-based review of topical and systemic treatments to inform clinical practice. JEADV. 2019; 33, 1863–1873.
Bilal H, Hou B, Shafiq M, Chen X, Shahid MA and Zeng Y. Antifungal susceptibility pattern of Candida isolated from cutaneous candidiasis patients in eastern Guangdong region: A retrospective study of the past 10 years. Front. Microbiol. 2022; 13:981181.
Parveen SD. An approach to etiology, diagnosis and management of different types of candidiasis. Journal of Yeast and Fungal Research. 2013; Vol. 4(6), pp. 63-74.
Alessandra O, Francesco GR, Malgorzata M, Federico P, Maurizio S, Carlo T, Mario V. Invasive Candida infection: epidemiology, clinical and therapeutic aspects of an evolving disease and the role of rezafungin. Expert Review of Anti-infective Therapy. 2023; 21:9, 957-975.
Alex S, Jeffrey BL, Oliver AC, Emmanuel R, Antonio RM, Patrick MH, Mariana C, Cecilia GC, SaadN, Matteo B, Nick M, Taylor S, Maiken CA. Clinical and mycological outcomes of candidaemia and/or invasive candidiasis by Candida spp. and antifungal susceptibility: pooled analyses of two randomized trials of rezafungin versus caspofungin. Clinical Microbiology and Infection. 2025; 31,250-257.
Ibanez-Nolla J, Nolla-Salas M. Multifocal candidiasis can be considered a form of invasive candidiasis in critically non-neutropenic patients, International Journal of Infectious Diseases. 2024; 147, 107171.
Todd PM, Cameron MW, Peter GP. Candidemia and Invasive Candidiasis, Infect Dis Clin N Am. 2021; 35, 389–413.
Pinello A, Laura M, Salvatore S, Massimo G, Mario C. Candidemia and invasive candidiasis in adults: A narrative review. Eur J Intern Med. 2016; 06.029
Todd PM, Peter GP. MD. Invasive Candidiasis, Infect Dis Clin N Am. 2015; 10.013
Ronen Ben-Ami, Treatment of Invasive Candidiasis: A Narrative Review,J. Fungi. 2018; 4, 97.
Alex S, Patrick MH, Pedro PA, Carolina GV, Anna P, Daniela CG, Paul E, Verweij A. Invasive candidiasis: current clinical challenges and unmet needs in adult populations,J AntimicrobChemother. 2023; 78: 1569–1585
Published
How to Cite
Issue
Section
Copyright (c) 2025 Paryekar Asawari, Shreya Talreja, Barse Rohan, Jagtap Vijay .
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.